Home / Business and Economy / Gilead and Expedia Stocks Surge as US Markets Hit New Highs
Gilead and Expedia Stocks Surge as US Markets Hit New Highs
8 Aug
Summary
- Gilead Sciences stock jumps 8.8% on strong Q2 earnings and raised guidance
- Expedia Group shares rise 4.4% after reporting encouraging financial results
- S&P 500, Nasdaq, and Dow Jones indexes make weekly gains
On August 8, 2025, the US stock market continued its recent upward momentum, with the S&P 500, Nasdaq, and Dow Jones indexes all posting weekly gains. Leading the charge were shares of Gilead Sciences Inc. (GILD) and Expedia Group Inc. (EXPE), which both reported strong second-quarter financial results.
Gilead Sciences, a prominent biopharmaceutical company, saw its stock surge 8.8% on the day, marking one of the biggest gains in the market. The company's earnings easily beat analysts' forecasts, and it also raised its full-year earnings guidance to $7.95-$8.25 per share. Analysts at Morgan Stanley and TD Cowen have since increased their price targets for Gilead, reflecting their bullish outlook.
Expedia Group, a major player in the online travel industry, also notched one of the market's largest gains, advancing 4.4% after reporting encouraging Q2 results. The company's stock performance has drawn mixed but generally bullish reactions from analysts, with J.P. Morgan, Melius, and Evercore ISI all raising their price targets.
The broader market rally was driven in part by strong performances from technology companies, which make up a significant portion of the S&P 500 and Nasdaq indexes. Nvidia and Microsoft were among the notable gainers, helping to push the Nasdaq to a new all-time high.
Despite the positive momentum, some have warned that current tariffs could still pose a risk to companies' profits and operations in the coming months.
